NRG Oncology Network Center: Coordinating Innovative Cancer Trials
Official title: NRG Oncology Network Group Operations Center
Funded at Nrg Oncology Foundation, INC. · NIH-11291689 · Data updated 2026-11-12
A large, patient-focused network coordinates and conducts trials to improve outcomes for adults with non-hematologic cancers such as breast, bladder, brain, and other tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nrg Oncology Foundation, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 17, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $13,144,395 |
| NIH project number | 2U10CA180868-12 |
| Project ID | NIH-11291689 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with breast, bladder, brain, gynecologic, prostate, head and neck, gastrointestinal, sarcoma, or other solid tumors who might participate in NRG-led or NCTN trials.
✕Less likely to help
Patients who do not fit trial eligibility or who are not offered a trial due to location or other barriers may not benefit.
What this research studies
This grant supports the NRG Oncology Network Operations Center, which leads clinical and translational trials across multiple cancer types in adults. The center helps organize, standardize, and speed patient-focused trials through collaboration with other groups in the National Cancer Trials Network. By coordinating trial enrollment and data sharing, it aims to make cutting-edge treatments more accessible to patients with localized or locally advanced disease. The program emphasizes sex-specific cancers and a broad range of solid tumors, with a track record of enrolling a large and diverse patient population.
Why it matters
Potential benefit: Patients could gain earlier access to promising treatments and contribute to faster improvements in cancer care.
How similar studies have gone: NRG has a history of substantial patient accrual and leadership within the NCTN, indicating successful trial participation and collaboration.
Where this research is happening
-
Nrg Oncology Foundation, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Wolmark, Norman — Nrg Oncology Foundation, INC.
- Study coordinator: Wolmark, Norman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.